• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Signia Launches Advanced Prescription-Grade Earbuds

by Syed Hamza Sohail 09/04/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Committed to helping hearing care professionals (HCPs) empower people with its breakthrough Integrated Xperience (IX) hearing aid platform, hearing aid innovator Signia has announced Signia Active Pro IX, a cutting-edge category of consumer earbuds that double as prescription-grade hearing aids and bring the power of conversation to even more wearers.

– Integrated Xperience is the world’s only hearing aid platform with RealTime Conversation Enhancement Technology, powered by split processing to independently enhance multiple conversation partners while separately reducing background sounds to keep them immersive but not distracting. 

Signia: Innovating Hearing Technology for Enhanced Human Performance

Signia is a global leader in hearing aid technology, committed to enhancing human performance through innovative solutions and consumer-friendly designs that shape the hearing health market. Since its inception in 2016, Signia has consistently introduced pioneering, industry-leading technologies, notably as a forerunner in rechargeable hearing aids.

Innovative Hearing Solutions and Consumer Engagement

Signia not only excels in creating advanced hearing aids but also provides tools and apps designed to elevate customer interaction and engagement across all aspects of hearing aid management. By partnering with hearing care professionals, Signia empowers hearing aid users to not only address hearing loss but to gain a competitive edge, embodying the motto: “Be Brilliant.”

Revolutionary RealTime Conversation Enhancement Technology

A highlight of Signia’s offerings is the RealTime Conversation Enhancement technology, which features a multi-stream architecture that can precisely track multiple moving conversation partners in real-time. This technology can process up to four focus streams simultaneously, analyzing, augmenting, and adapting to the dynamic nature of multi-party conversations. Studies have demonstrated the effectiveness of Signia’s Integrated Xperience platform, with 95% of participants reporting improved speech clarity and an impressive +12dB (SNR) in noisy group conversation scenarios. Additionally, 80% of participants in a peer-reviewed study preferred using RealTime Conversation Enhancement in real-world noisy environments.

Signia Active Pro IX: Redefining Hearing Aid Design

Signia is expanding the hearing aid market with the introduction of the Signia Active Pro IX, a device that reimagines hearing aids as consumer-style earbuds. This product is designed to appeal to individuals with hearing loss who may resist traditional hearing aid designs but still seek superior performance during activities such as exercising, working, or socializing.

The Signia Active Pro IX is available in various colors, features a rechargeable battery for all-day use, and includes a convenient charging case for on-the-go recharging. Similar to consumer earbuds, it supports Bluetooth connectivity for audio streaming and hands-free smartphone communication. With its IP68 rating, the Active Pro IX is resistant to dust, water, and sweat, making it ideal for active users.

Expanding Access to Innovative Hearing Technology

To further broaden its market reach, Signia is launching the Active IX earbuds, which offer the same modern earbud design as the Active Pro IX at a more affordable price. The Active IX features advanced technologies such as Signia’s Augmented Focus, automatic directionality, and audio streaming connectivity. By offering both the Active Pro IX and Active IX at different technology levels, Signia demonstrates its commitment to making cutting-edge hearing technology more accessible.

Signia is also introducing the IX Essentials line in the U.S. market, expanding the Integrated Xperience portfolio with performance levels 2IX and 1IX across select models, including Signia Pure Charge&Go IX, Styletto IX, Silk Charge&Go IX, and Insio IX hearing aids. This expansion ensures that more people can benefit from the Integrated Xperience platform, enjoying the enhanced conversational capabilities it provides.

“Signia Active Pro IX offers our HCP partners a modern, low-profile solution for people who need to boost their hearing but might not otherwise accept hearing aids right now,” said Jens Møller, Global Head of Signia Brand. “In addition to a contemporary earbud design, Signia Active Pro IX delivers the full power of Integrated Xperience technology, empowering wearers to reconnect with conversations and engage fully regardless of their environment.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |